Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa - John J. Mitchell; Jose E. Abdenur; Foekje de Boer; Monica Boyer; Margo Sheck Breilyn; María‐Luz Couce; Diva D. De Leon; Terry G. Derks; Areeg El‐Gharbawy; Andrea B. Haijer‐Schreuder; Karen Loechner; Nicola Longo; et al. (Journal of Inherited Metabolic Disease, 2026)